• Sorafenib 'New Standard of Care' for Patients With Desmoid Tumors

    5 monthes ago - By MedPageToday

    Skin rash and disorders led to treatment discontinuation in 20% of patients
    Read more ...


  • Desmoid Tumors: Treatment Breakthrough With Sorafenib

    5 monthes ago - By Medscape

    Desmoid tumors, a rare form of sarcoma, may finally have a standard of care after a National Cancer Institute trial showed that sorafenib was able to reduce progression rates by more than 85%.
    Medscape Medical News
    Read more ...